This Education Program is designed to enable participants to test for, manage and treat hepatitis C. Course participants will have the confidence, knowledge and clinical decision-making skills to be able to prescribe DAAs for the treatment of HCV infection, either independently or in collaboration with a specialist as appropriate.
This course is being offered in collaboration with The Kirby Institute, UNSW
The course will be delivered in three parts:
• Part 1: consists of a 2 hour eLearning component introducing the learner to the assessment, management and treatment of hepatitis C in drug and alcohol settings
• Part 2: consists of an interactive face-to-face workshop building on the knowledge and skills gained in Part 1 through practical case discussions and simulation-based models
• Part 3: consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.
Addiction Specialists, Physicians, General Practitioners, Nurse Practitioners and other clinical staff interested in treating hepatitis C
Morning Tea, Lunch and Afternoon Tea to be provided.
For further Information Contact:
Natalie Huska (Project support Officer):
T 02 8204 0784
Conditions of registration:
Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 28 March 2017 will not incur a cancellation fee. Cancellations received in writing after 28 March 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.
As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to email@example.com.